Tandem Diabetes Care Inc. has raised $36.4 million of $50 million goal in a private financing venture.
The money raised form this financing will be used to expand the company’s sales and marketing capacity.
It will also be used to fund customer support systems and in research and development, said a company spokesman
Investors: Domain Associates, Delphi Ventures, TPG Biotechnology, HLM Venture Partners, Howard Greene Jr. and John Livingston.
For further deal information visit Current Agreements (subscription required)
Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Financing Scorecard – view top life science financing deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard– latest trends in big pharma deal making activity